Developer docs
API playgroundTry for free, no card

Search company profiles

CTGT

Full company profile

uuid000dtoc

Namestring
CTGT
Legal namestring
HNL Lab Medicine
Websiteurl
ctgt.net
Company typeenum
Private
Founded yearint
2004
Descriptiontext

HNL Genomics (formerly Connective Tissue Gene Tests, CTGT) is the clinical genomics division of HNL Lab Medicine, a private regional clinical laboratory headquartered in the Lehigh Valley of Pennsylvania with over 50 patient service center locations. The division provides molecular diagnostic testing across three operating units — Inherited Genetics, Cytogenetics, and Molecular Diagnostics — covering oncology, prenatal (including non-invasive prenatal screening), cardiology, and inherited genetic disorders. Its test portfolio supports physicians, genetic counselors, hospitals, health systems, and clinics in the Lehigh Valley region and into New York State.

The underlying technology stack combines Next Generation Sequencing (NGS) for variant-level analysis, chromosome microarray for high-resolution copy-number detection, fluorescence in situ hybridization (FISH) for targeted cytogenetic interrogation, and the MetaSystems platform for automated karyotyping and FISH image analysis. The lab holds CAP accreditation and references additional licensure, certifications, and accreditation documentation, supporting contracting with institutional providers and out-of-state referral work. Distribution runs through a regional patient service center network, a provider portal for direct physician ordering, courier specimen pickup for healthcare facilities, and HNL @Home for homebound patients.

Revenue is generated through fee-for-service clinical laboratory testing billed to healthcare providers, insurance payors, and patients. The go-to-market is a B2B enterprise field sales motion targeting physicians, genetic counselors, and institutional accounts, supplemented by direct-to-consumer test ordering. Pricing is not publicly disclosed; inquiries are routed through a genomics phone line and dedicated email channel.

Short descriptiontext

HNL Genomics (formerly CTGT / Connective Tissue Gene Tests) is the clinical genomics division of HNL Lab Medicine, providing molecular diagnostic testing in inherited genetics, cytogenetics, and molecular oncology, prenatal, and cardiology for physicians, genetic counselors, hospitals, and patients across the Lehigh Valley region.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersAllentown, United States
HQ citystring
Allentown
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
molecular diagnostic testing, clinical genetic testing, cytogenetic analysis services, inherited disorder testing, prenatal genetic screening
Industry4 codes
PRIMARYHLAFAMAE
Molecular Diagnostics & Genomics Laboratories
SECONDARYHLAFAMAH
Genetic & Prenatal Testing Laboratories
SECONDARYHLAGANAA
Genomics & Next-Generation Sequencing (NGS) Services
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Specialty Lab Services (Genomics/Proteomics/Cellomics)
SECONDARYHLAHAAAI
Genetic, Cytogenetic & Prenatal Screening IVD
Healthcare & Life Sciences/Medical Devices & Diagnostics/In Vitro Diagnostics (IVD) & Laboratory Diagnostics
NAICS code2 codes
  • Medical Laboratories621511
  • Medical and Diagnostic Laboratories6215
SIC code1 code
  • Services-Medical Laboratories8071
Product category
Clinical Genetic Testing Services
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Clinical Laboratory Genetic Testing Services
TypeProfessional Services
Description

HNL Genomics provides genetic testing services to healthcare providers and patients, operating as a diagnostic laboratory within HNL Lab Medicine. Revenue is generated through laboratory testing services billed to healthcare providers, insurance companies, and patients. Services span three divisions: Inherited Genetics, Cytogenetics, and Molecular Diagnostics covering oncology, prenatal, and cardiology specialties.

hnl.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels5 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

HNL Genomics (formerly Connective Tissue Gene Tests / CTGT) is a clinical laboratory that performs molecular diagnostic and cytogenetic testing for inherited genetic disorders, cancer, prenatal indications, and cardiology. Testing is delivered across three divisions — Inherited Genetics, Cytogenetics, and Molecular Diagnostics — using Next Generation Sequencing, chromosome microarray, FISH, and MetaSystems-based karyotyping to support physician diagnosis, prognosis, recurrence-risk assessment, and targeted therapy selection.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

HNL Genomics (formerly Connective Tissue Gene Tests, CTGT) is a genetic testing services provider organized into three integrated divisions: Inherited Genetics, Cytogenetics, and Molecular Diagnostics. These divisions work together to provide comprehensive genomic testing across specialties including Oncology, Prenatal, Cardiology, and Inherited Genetics, offering diagnostic results that aid in the development of specialized treatment plans for patients.

Product and service1 record
1Inherited Genetics Division Testing Services
Scale indicator1 record

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeTechnology or Integration
Description

HNL Genomics utilizes MetaSystems technology for automated karyotyping and fluorescence in situ hybridization (FISH) analysis in their cytogenetics laboratory. MetaSystems provides advanced imaging and analysis platforms for chromosome analysis supporting the diagnosis, prognosis, and monitoring of oncologic malignancies.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

National clinical reference laboratory with an extensive genetic and molecular diagnostics menu (including Quest's own NIPS and hereditary cancer offerings). Competes with HNL Genomics across all three divisions, but as a broad-line incumbent rather than a genomics specialist.

TypeBroad incumbent
Description

National reference laboratory affiliated with the University of Utah offering esoteric genetic, molecular, and cytogenetic testing. Comparable to HNL Genomics' reference/esoteric positioning, especially in cytogenetics and inherited disorders.

TypeDirect peer
Description

Specialized molecular diagnostics company with strong prenatal (NIPS), oncology, and transplant testing offerings. Directly comparable to HNL Genomics' prenatal screening and molecular oncology divisions on technology and clinician customers.

TypeBroad incumbent
Description

National reference lab offering integrated clinical and genetic/molecular diagnostic services including NIPS, oncology, and inherited disorder panels. Comparable on test menu and payer relationships, with substantially broader geographic reach.

TypeDirect peer
Description

Labcorp specialty genetics lab offering reproductive and prenatal genetic testing including NIPS and carrier screening. Directly comparable to HNL Genomics' prenatal screening division on test type and clinician customer.

TypeDirect peer
Description

Clinical genomics lab specializing in rare disease and pediatric hereditary testing using exome and genome sequencing. Comparable to HNL Genomics' inherited genetics division in target clinicians and test methodology.

TypeDirect peer
Description

Genetic testing company offering hereditary cancer, reproductive health, and rare disease panels via NGS. Closely comparable to HNL Genomics' inherited genetics and molecular diagnostics divisions in test menu and clinical customer base.

TypeDirect peer
Description

Clinical genetic testing lab (now part of Konica Minolta) offering hereditary cancer, reproductive, and rare disease panels via NGS. Closely comparable to HNL Genomics' inherited genetics and molecular diagnostics offerings.

TypeDirect peer
Description

Established genetic testing lab focused on hereditary cancer, prenatal, and pharmacogenomics. Comparable to HNL Genomics on specialty genetic testing menu and clinician-driven GTM motion.

TypeDirect peer
Description

Clinical DNA testing laboratory (part of Exact Sciences) offering hereditary cancer, cardiac, and rare disease genetic testing. Comparable on multi-specialty genetic test menu and clinician ordering workflow.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks4 records

Each record includes

Headline, Details, Source

Key highlights5 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

CTGT

Clinical Genetic Testing Servicesctgt.net

HNL Genomics (formerly CTGT / Connective Tissue Gene Tests) is the clinical genomics division of HNL Lab Medicine, providing molecular diagnostic testing in inherited genetics, cytogenetics, and molecular oncology, prenatal, and cardiology for physicians, genetic counselors, hospitals, and patients across the Lehigh Valley region.

What CTGT does

HNL Genomics (formerly Connective Tissue Gene Tests, CTGT) is the clinical genomics division of HNL Lab Medicine, a private regional clinical laboratory headquartered in the Lehigh Valley of Pennsylvania with over 50 patient service center locations. The division provides molecular diagnostic testing across three operating units — Inherited Genetics, Cytogenetics, and Molecular Diagnostics — covering oncology, prenatal (including non-invasive prenatal screening), cardiology, and inherited genetic disorders. Its test portfolio supports physicians, genetic counselors, hospitals, health systems, and clinics in the Lehigh Valley region and into New York State.

The underlying technology stack combines Next Generation Sequencing (NGS) for variant-level analysis, chromosome microarray for high-resolution copy-number detection, fluorescence in situ hybridization (FISH) for targeted cytogenetic interrogation, and the MetaSystems platform for automated karyotyping and FISH image analysis. The lab holds CAP accreditation and references additional licensure, certifications, and accreditation documentation, supporting contracting with institutional providers and out-of-state referral work. Distribution runs through a regional patient service center network, a provider portal for direct physician ordering, courier specimen pickup for healthcare facilities, and HNL @Home for homebound patients.

Revenue is generated through fee-for-service clinical laboratory testing billed to healthcare providers, insurance payors, and patients. The go-to-market is a B2B enterprise field sales motion targeting physicians, genetic counselors, and institutional accounts, supplemented by direct-to-consumer test ordering. Pricing is not publicly disclosed; inquiries are routed through a genomics phone line and dedicated email channel.

CTGT firmographics

Firmographics
Name
CTGT
Legal name
HNL Lab Medicine
Website
https://ctgt.net
Company type
Private
Founded year
2004
Operating status
Operating
Headcount range
1–10 employees
Short description
HNL Genomics (formerly CTGT / Connective Tissue Gene Tests) is the clinical genomics division of HNL Lab Medicine, providing molecular diagnostic testing in inherited genetics, cytogenetics, and molecular oncology, prenatal, and cardiology for physicians, genetic counselors, hospitals, and patients across the Lehigh Valley region.
Ownership category
akta.pro rank

CTGT industry classification

Industry
Product category
Clinical Genetic Testing Services
NAICS
Medical Laboratories (621511), Medical and Diagnostic Laboratories (6215)
SIC
Services-Medical Laboratories (8071)
akta.pro industry
PRIMARYHLAFAMAE
Molecular Diagnostics & Genomics Laboratories
SECONDARYHLAFAMAH
Genetic & Prenatal Testing Laboratories
SECONDARYHLAGANAA
Genomics & Next-Generation Sequencing (NGS) Services
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Specialty Lab Services (Genomics/Proteomics/Cellomics)
SECONDARYHLAHAAAI
Genetic, Cytogenetic & Prenatal Screening IVD
Healthcare & Life Sciences/Medical Devices & Diagnostics/In Vitro Diagnostics (IVD) & Laboratory Diagnostics

Keywords

  • Molecular diagnostic testing
  • Clinical genetic testing
  • Cytogenetic analysis services
  • Inherited disorder testing
  • Prenatal genetic screening

Where CTGT is headquartered

Location

Headquarters

HQ city
Allentown
HQ country
United States
HQ region
North America

Offices1 record

Markets served

CTGT business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

  1. Clinical Laboratory Genetic Testing Services: HNL Genomics provides genetic testing services to healthcare providers and patients, operating as a diagnostic laboratory within HNL Lab Medicine. Revenue is generated through laboratory testing services billed to healthcare providers, insurance companies, and patients. Services span three divisions: Inherited Genetics, Cytogenetics, and Molecular Diagnostics covering oncology, prenatal, and cardiology specialties.

Go-to-market motion1 record

Distribution channels5 records

Marketing channels4 records

CTGT product offering

Product offering

Core offering

HNL Genomics (formerly Connective Tissue Gene Tests / CTGT) is a clinical laboratory that performs molecular diagnostic and cytogenetic testing for inherited genetic disorders, cancer, prenatal indications, and cardiology. Testing is delivered across three divisions — Inherited Genetics, Cytogenetics, and Molecular Diagnostics — using Next Generation Sequencing, chromosome microarray, FISH, and MetaSystems-based karyotyping to support physician diagnosis, prognosis, recurrence-risk assessment, and targeted therapy selection.

Product overview

HNL Genomics (formerly Connective Tissue Gene Tests, CTGT) is a genetic testing services provider organized into three integrated divisions: Inherited Genetics, Cytogenetics, and Molecular Diagnostics. These divisions work together to provide comprehensive genomic testing across specialties including Oncology, Prenatal, Cardiology, and Inherited Genetics, offering diagnostic results that aid in the development of specialized treatment plans for patients.

Differentiator

Problem solved

Functional benefit

Products and services

  • Inherited Genetics Division Testing Services

Companies that use CTGT

Customer profile

Segments3 records

Ideal customer profiles1 record

CTGT technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

CTGT partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • MetaSystemscoreTechnology or IntegrationHNL Genomics utilizes MetaSystems technology for automated karyotyping and fluorescence in situ hybridization (FISH) analysis in their cytogenetics laboratory. MetaSystems provides advanced imaging and analysis platforms for chromosome analysis supporting the diagnosis, prognosis, and monitoring of oncologic malignancies.

Scale indicators1 record

Recent moves6 records

Expansion highlights5 records

CTGT competitors and assessment

Company assessment

Broad incumbents

  • Quest Diagnostics: National clinical reference laboratory with an extensive genetic and molecular diagnostics menu (including Quest's own NIPS and hereditary cancer offerings). Competes with HNL Genomics across all three divisions, but as a broad-line incumbent rather than a genomics specialist.
  • ARUP Laboratories: National reference laboratory affiliated with the University of Utah offering esoteric genetic, molecular, and cytogenetic testing. Comparable to HNL Genomics' reference/esoteric positioning, especially in cytogenetics and inherited disorders.
  • Labcorp: National reference lab offering integrated clinical and genetic/molecular diagnostic services including NIPS, oncology, and inherited disorder panels. Comparable on test menu and payer relationships, with substantially broader geographic reach.

Direct peers

  • Natera: Specialized molecular diagnostics company with strong prenatal (NIPS), oncology, and transplant testing offerings. Directly comparable to HNL Genomics' prenatal screening and molecular oncology divisions on technology and clinician customers.
  • Integrated Genetics (Labcorp Specialty Testing): Labcorp specialty genetics lab offering reproductive and prenatal genetic testing including NIPS and carrier screening. Directly comparable to HNL Genomics' prenatal screening division on test type and clinician customer.
  • GeneDx: Clinical genomics lab specializing in rare disease and pediatric hereditary testing using exome and genome sequencing. Comparable to HNL Genomics' inherited genetics division in target clinicians and test methodology.
  • Invitae: Genetic testing company offering hereditary cancer, reproductive health, and rare disease panels via NGS. Closely comparable to HNL Genomics' inherited genetics and molecular diagnostics divisions in test menu and clinical customer base.
  • Ambry Genetics: Clinical genetic testing lab (now part of Konica Minolta) offering hereditary cancer, reproductive, and rare disease panels via NGS. Closely comparable to HNL Genomics' inherited genetics and molecular diagnostics offerings.
  • Myriad Genetics: Established genetic testing lab focused on hereditary cancer, prenatal, and pharmacogenomics. Comparable to HNL Genomics on specialty genetic testing menu and clinician-driven GTM motion.
  • PreventionGenetics: Clinical DNA testing laboratory (part of Exact Sciences) offering hereditary cancer, cardiac, and rare disease genetic testing. Comparable on multi-specialty genetic test menu and clinician ordering workflow.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks4 records

Key highlights5 records

Customer concentration

CTGT social profiles

Digital presence

CTGT compliance and trust

Trust signal

Compliance1 record

CTGT financial estimates

Financial estimate

Revenue estimate

Valuation estimate

CTGT leadership team

Management profile

Number of profiles

CTGT funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

CTGT M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about CTGT

What does CTGT do?

HNL Genomics (formerly Connective Tissue Gene Tests / CTGT) is a clinical laboratory that performs molecular diagnostic and cytogenetic testing for inherited genetic disorders, cancer, prenatal indications, and cardiology. Testing is delivered across three divisions — Inherited Genetics, Cytogenetics, and Molecular Diagnostics — using Next Generation Sequencing, chromosome microarray, FISH, and MetaSystems-based karyotyping to support physician diagnosis, prognosis, recurrence-risk assessment, and targeted therapy selection.

Is CTGT a public or private company?

CTGT is a private company. It is classified as corporate owned and is currently operating.

When was CTGT founded?

CTGT was founded in 2004. It employs 1 to 10 people.

Where is CTGT based?

CTGT is headquartered in Allentown, United States, in the North America region.

How does CTGT make money?

One revenue line is on record: clinical Laboratory Genetic Testing Services.

Who are CTGT's main competitors?

Broad incumbents on record are Quest Diagnostics, ARUP Laboratories and Labcorp. Direct peers are Natera, Integrated Genetics (Labcorp Specialty Testing), GeneDx, Invitae, Ambry Genetics, Myriad Genetics and PreventionGenetics.

Does CTGT have an API?

No public API is recorded for CTGT.

What industry is CTGT in?

CTGT's product category is Clinical Genetic Testing Services. Its primary akta.pro industry code is HLAFAMAE, Molecular Diagnostics & Genomics Laboratories, with a secondary code of HLAFAMAH, Genetic & Prenatal Testing Laboratories. Its NAICS code is 621511 and its SIC code is 8071.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales